We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blocking Uncontrolled Calcium Flux Protects the Brain from Stroke Damage

By LabMedica International staff writers
Posted on 04 Feb 2010
Print article
Preventing the binding of a proapoptotic enzyme during stroke (cerebral ischemia) protected the brain from damage caused by the unregulated transport of calcium ions into nerve cells.

Investigators at the University of Central Florida (Orlando, USA) and their collaborators at Louisiana State University (New Orleans, USA) worked with a mouse stroke model. They focused their efforts on understanding the role of an enzyme called death-associated protein kinase 1 (DAPK1), which was known to be a positive mediator of gamma-interferon induced programmed cell death.

The Investigators found that under the traumatic conditions induced by a stroke DAPK1 attached to and blocked the activity of NMDA (N-methyl-D-aspartate) receptors that normally control calcium flux in nerve cells. Lacking NMDA receptor control, nerve cells became overloaded with calcium and died.

To prevent damage from calcium overload the investigators resorted to two different types of therapy. In one study, they used gene-silencing techniques to eliminate DAPK1 from nerve cells. In another, they treated brain tissue with a soluble polypeptide, NR2BCT, which mimicked the region of the NMDA receptor that binds DAPK1. The peptide bound to DAPK1 more efficiently and prevented the enzyme from attaching to the NMDA receptor. In both cases, the treatment protected brain cells against stroke injury, and did not affect the normal physiological functions of the receptors.

Results published in the January 22, 2010, issue of the journal Cell confirmed that DAPK1 physically and functionally interacted with the NMDA receptor NR2B subunit at extrasynaptic sites, and this interaction acted as a central mediator for stroke damage.

"It is conceivable that this study not only provides new insights into the cellular and molecular basis responsible for stroke damage, but also provides a therapeutic target for stroke therapy," said senior author Dr. Youming Lu, professor of neurosciences at Louisiana State University.

Related Links:
University of Central Florida
Louisiana State University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Food Allergens Assay Kit
Allerquant 14G A
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.